Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis.
Seokhun Yang,Jeehoon Kang,Doyeon Hwang,Jinlong Zhang,Jun Jiang,Xinyang Hu,Joo-Yong Hahn,Chang-Wook Nam,Joon-Hyung Doh,Bong-Ki Lee,Weon Kim,Jinyu Huang,Fan Jiang,Hao Zhou,Peng Chen,Lijiang Tang,Wenbing Jiang,Xiaomin Chen,Wenming He,Sung Gyun Ahn,Myeong-Ho Yoon,Ung Kim,Joo Myung Lee,You-Jeong Ki,Eun-Seok Shin,Hyo-Soo Kim,Seung-Jea Tahk,Jian'an Wang,Bon-Kwon Koo
DOI: https://doi.org/10.1001/jamanetworkopen.2023.50036
2024-01-01
JAMA Network Open
Abstract:Importance: Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies.Objectives: To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment.Design, setting, and participants: This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] <= 3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] >= 70%) or an FFR-guided strategy (which recommended PCI for FFR <= 0.80). Data were analyzed from November to December 2022.Exposures: FFR or IVUS parameters within the deferred and revascularized vessels.Main outcomes and measures: The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years.Results: A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001).Conclusions and relevance: In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.